A team of researchers led by Scott Hensley (University of Pennsylvania) has developed an mRNA vaccine that encodes proteins from all 20 known subtypes of influenza A and B viruses. The new experimental vaccine is showing promise in animal trials, raising hopes that the same mRNA technology that enabled the leading COVID-19 vaccines will tamp down future flu outbreaks.